Larimar Therapeutics, Inc. (LRMR) Covered Calls

Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases. The company's lead compound is CTI-1601, a Phase 1 clinical program to treat Friedreich's ataxia, a rare and progressive genetic disease. The company is headquartered in Bala Cynwyd, Pennsylvania.

You can sell covered calls on Larimar Therapeutics, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for LRMR (prices last updated Fri 4:16 PM ET):

Larimar Therapeutics, Inc. (LRMR) Stock Quote
Last	Change	Bid	Ask	Volume	P/E	Market Cap
6.69	-0.88	6.51	6.68	939K	-	0.5

Covered Calls For Larimar Therapeutics, Inc. (LRMR)
Expiration	Strike	Call Bid	Net Debit	Return If Flat	Annualized Return If Flat
Dec 20	7.5	0.50	6.18	8.1%	82.1%
Jan 17	7.5	0.60	6.08	9.9%	56.5%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls? Sign Up For A Free Trial

Top 10 Open Interest For Dec 20 Expiration				Top 5 High Yield
1.	NVDA covered calls	6.	QQQ covered calls	1.	SAVA covered calls
2.	SPY covered calls	7.	XLF covered calls	2.	RKLB covered calls
3.	EEM covered calls	8.	KWEB covered calls	3.	LUNR covered calls
4.	FXI covered calls	9.	TLT covered calls	4.	NMRA covered calls
5.	IWM covered calls	10.	KRE covered calls	5.	CRVS covered calls

Want more examples? LRGF Covered Calls | LRN Covered Calls